Pharmacists in Hazlehurst, Mississippi


12 Pharmacists found in Hazlehurst
female pharmacist

Dr. Deborah Torres Ratliff


Pharmacist
527 Lake St, Hazlehurst, MS 39083
601-894-1476    

male pharmacist

Jerry Wayne Owen, RPH


Pharmacist
527 Lake St, Hazlehurst, MS 39083
601-894-1476    

female pharmacist

Ms. Kathleen Mary Rose, R.PH.


Pharmacist
218 Caldwell Dr, Hazlehurst, MS 39083
601-894-1222     601-894-1522



female pharmacist

Dr. Katlynn A Sullivan, PHARMD


Pharmacist
28095 Highway 28, Hazlehurst, MS 39083
601-894-5501     601-894-5721

female pharmacist

Dr. Katrina Martinez Smythe, PHARM. D


Pharmacist
28095 Highway 28, Hazlehurst, MS 39083
601-894-5501     601-894-5721

female pharmacist

Kayla Elise Massey, PHARMD


Pharmacist
527 Lake St, Hazlehurst, MS 39083
601-894-1476    

female pharmacist

Dr. Laquita L. Johnson, PHARMD


Pharmacist - Pharmacotherapy
102 Williams Street, Hazlehurst, MS 39083
601-622-6165    

male pharmacist

Michael Henry Rose, RPH


Pharmacist
218 Caldwell Dr, Hazlehurst, MS 39083
601-894-1222     601-894-1522

female pharmacist

Dr. Remonica Shanta Mcbride


Pharmacist
527 Lake St, Hazlehurst, MS 39083
601-894-1476    

male pharmacist

Roger Dale Blakeney, RPH


Pharmacist
28095 Highway 28, Hazlehurst, MS 39083
601-894-5501     601-894-5721

male pharmacist

Troy Donald Douglas, R.PH.


Pharmacist
218 Caldwell Dr, Hazlehurst, MS 39083
601-894-1222     601-894-1522

female pharmacist

Mrs. Vicki B. Johns, R.PH.


Pharmacist
218 Caldwell Dr, Hazlehurst, MS 39083
601-894-1222     601-894-1522


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.